Liyfe is the first AI-based digital nurse, enabling symptom and risk assessment for oncology and NASH patients. Using this tool, patients can understand the severity of their symptoms while data on potential risks and complications are communicated to the clinical care team in real time. The Liyfe digital nurse can be used to improve patient quality of life and outcomes, increase adherence and persistence, reduce ER visits and hospitalization, and reduce on-site monitoring needs and cost, while providing valuable longitudinal real-world data (RWD) in clinical trials as well as for marketed products.
